As of Mar 20
| -0.0007 / -2.53%|
The 1 analysts offering 12-month price forecasts for Immune Therapeutics Inc have a median target of 0.61, with a high estimate of 0.61 and a low estimate of 0.61. The median estimate represents a +2,159.26% increase from the last price of 0.03.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.